Annual Secretarial Compliance report under Regulation 24(A)
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
PSK & Associates, Practicing Company Secretary, submitted the annual secretarial compliance report for Concord Drugs Ltd covering FY 2025-26. The report examined compliance across multiple SEBI regulations including LODR 2015, ICDR 2018, SAST 2011, PIT Regulations, and Depositories Regulations. Three deviations were identified: (1) late submission of demat reconciliation report under Regulation 76 by 27 days, for which BSE issued an advisory citing administrative challenges; (2) missing mandatory disclosures on the company website under Regulation 46, with management stating the website is being updated; and (3) non-appointment of a Company Secretary for Q4 Dec-23 and Q1 March-24, for which the company paid SOP fines of ₹2,00,600. All other compliance areas including secretarial standards, insider trading, related party transactions, and document preservation were found satisfactory. No additional non-compliances were observed beyond those listed.
The report highlights minor compliance gaps with no material impact on operations. The company has addressed the Company Secretary vacancy by paying fines and is working on website updates. The late filing and website issues received BSE advisories rather than heavy penalties, suggesting manageable regulatory risk for shareholders.